• 1. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 2. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines Pyrrolopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines

Professional Introduction to 4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridin-6-amine (CAS No. 943323-56-6)

4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridin-6-amine is a highly specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound, identified by its CAS number 943323-56-6, is characterized by its complex heterocyclic structure, which includes a pyrrolopyridine core appended with a tetramethylborate group. The unique structural features of this molecule make it a promising candidate for various applications, particularly in the development of novel therapeutic agents.

The pyrrolopyridine scaffold is a privileged structure in drug discovery due to its presence in numerous bioactive molecules. Pyrrolopyridines are known for their ability to interact with biological targets such as enzymes and receptors, making them valuable in the design of small-molecule drugs. The incorporation of a boronic acid derivative in this compound adds another layer of functionality, enabling potential applications in cross-coupling reactions commonly used in synthetic organic chemistry. This makes 4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridin-6-amine a versatile building block for the synthesis of more complex molecules.

Recent advancements in medicinal chemistry have highlighted the importance of boronic acid-containing compounds in drug development. Boronic acids and their derivatives are widely recognized for their role in various biological processes and have been successfully incorporated into drugs targeting diseases such as cancer and inflammation. The boron atom in these compounds can participate in stable interactions with biological molecules, leading to enhanced binding affinity and improved pharmacological activity. The use of tetramethylborate groups further enhances the stability and reactivity of these compounds, making them more suitable for pharmaceutical applications.

In the context of current research, 4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridin-6-amine has shown potential in the development of targeted therapies. Pyrrolopyridine-based molecules have been explored for their anti-inflammatory, antiviral, and anticancer properties. For instance, studies have demonstrated that pyrrolopyridines can modulate enzyme activity by binding to specific pockets on the enzyme surface. The presence of the boronic acid group allows for further functionalization through Suzuki-Miyaura cross-coupling reactions, enabling the creation of diverse derivatives with tailored biological activities.

The synthesis of this compound involves multiple steps that require precise control over reaction conditions to ensure high yield and purity. The introduction of the tetramethylborate group necessitates careful handling to prevent unwanted side reactions. Advanced synthetic techniques such as transition-metal catalysis are often employed to facilitate these transformations efficiently. The use of palladium or copper catalysts can enhance the cross-coupling reactions, leading to better overall yields and fewer byproducts.

The pharmacological potential of 4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridin-6-amine has been investigated through both computational and experimental studies. Computational methods such as molecular docking and molecular dynamics simulations have been used to predict how this compound might interact with biological targets. These studies provide valuable insights into the binding affinity and mode of action of the molecule, helping researchers design more effective therapeutic agents.

In vitro studies have also been conducted to evaluate the biological activity of this compound. Initial results suggest that it exhibits promising properties as an inhibitor of certain enzymes involved in disease pathways. For example, it has shown potential in inhibiting kinases that are overexpressed in cancer cells. Additionally, its ability to modulate inflammatory responses has been observed in preliminary experiments using cell-based models.

The future development of 4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridin-6-amine as a therapeutic agent will likely involve further optimization and characterization. Researchers will focus on improving its pharmacokinetic properties, such as solubility and bioavailability, to enhance its clinical potential. Additionally, detailed toxicological studies will be necessary to ensure its safety for human use.

The versatility of this compound also makes it an attractive candidate for research purposes beyond drug development. Its unique structure can serve as a starting point for exploring new synthetic methodologies and exploring novel chemical space. By modifying different parts of its molecular framework, scientists can generate a library of derivatives with diverse properties and functions.

The integration of computational chemistry with experimental techniques has significantly accelerated the discovery process for new pharmaceuticals. By leveraging computational tools early in the discovery pipeline, researchers can rapidly screen large libraries of compounds for potential hits. This approach has been particularly effective for complex molecules like 4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridin-6-amine, where traditional screening methods might be less efficient.

In conclusion, 4-(tetramethyl-1，3，2-dioxaborolan - 2 - yl) - 1H - pyrrol o [ 2， 3 - b ] py ridin - 6 - am ine( CAS No . 943323 - 56 - 6 ) is a multifaceted compound with significant potential in pharmaceutical research . Its unique structural features , combined with its reactivity and biological activity , make it a valuable tool for developing new therapeutic agents . As research continues , this compound is expected to play an important role in advancing our understanding of disease mechanisms and developing innovative treatments .

• 754214-56-7(5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine)
• 2161304-72-7(6-(Tetramethyl-1,3,2-dioxaborolan-2-yl)quinolin-2-amine)
• 2056916-60-8(8-(tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-amine)
• 1610521-57-7(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine hydrochloride)
• 1210048-27-3(1-Isoquinolinamine, 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-)
• 1195995-72-2(4-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine)
• 1626337-92-5(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1-amine)
• 2143040-51-9(6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-amine)
• 945256-29-1(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine)
• 942919-26-8(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-YL)-1H-pyrrolo[2,3-B]pyridine)